US firms selling unapproved 'stem cell treatments'
Miami
HUNDREDS of companies across the United States are selling unapproved stem cell treatments directly to patients, raising concerns about safety and scams in a fast-growing industry, researchers said on Thursday.
At least 351 companies across the United States are marketing unapproved stem cell procedures at 570 individual clinics, the researchers' report in the journal Cell Stem Cell found.
The clinics claimed to offer "stem cell interventions" for muscle and bone dis…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
P&G raises annual core profit forecast on resilient demand, price hikes
Cordlife calls for trading halt after shares sink to all-time low, pending announcement
Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom
Swiss watch exports plunge as China and Hong Kong demand dries up
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO